Tirzepatide Weight Loss in Florida
Mounjaro & Zepbound: The most powerful GLP-1 medication available
Tirzepatide is a first-in-class dual-action medication that targets both GIP and GLP-1 receptors, producing the highest average weight loss seen in any medication trial. Our physicians evaluate, prescribe, and guide you to cost-effective medication options, all via telehealth.
Vandhana Kiswani-Barley, MD
Triple Board-Certified + FACHE · 15+ Years Experience
Why Tirzepatide?
Clinical trials showed tirzepatide produced remarkable weight loss results: up to 22.5% of body weight.
Up to 22.5% Weight Loss
Clinical trials show superior results vs. other GLP-1s
Dual Hormone Action
Targets both GIP and GLP-1 for enhanced effects
Blood Sugar Control
Excellent for patients with diabetes or prediabetes
Cardiovascular Benefits
May reduce heart disease risk factors
Appetite Reduction
Significant decrease in hunger and cravings
Sustained Results
Long-term weight maintenance with proper support
Tirzepatide vs Semaglutide
Both are effective, but tirzepatide's dual mechanism often produces greater results.
| Comparison | Tirzepatide | Semaglutide |
|---|---|---|
| Average Weight Loss | 20-22% | 15-17% |
| Mechanism | Dual GIP + GLP-1 | GLP-1 only |
| Frequency | Once weekly | Once weekly |
| FDA Approved (Weight) | Yes (Zepbound) | Yes (Wegovy) |
| Diabetes Formulation | Mounjaro | Ozempic |
How It Works
Consultation
Discuss your goals with Dr. Kiswani-Barley via telehealth ($250 initial evaluation)
Comprehensive Labs
Access Labs (preferred) or Quest Diagnostics with insurance
Personalized Plan
Dr. Kiswani-Barley creates a customized treatment protocol
Get Your Prescription
We prescribe and guide you to cost-effective pharmacy options like LillyDirect
Ongoing Support
Follow-up visits ($200), dose adjustments, and coaching as needed